The Quantitative Imaging Workshop (QIW) XX will take place on November 2-3, 2023. This is a virtual, high-impact, multi-disciplinary forum for the advancement of quantitative CT imaging biomarkers for early thoracic disease management. Attendees will explore exciting new biomedical opportunities that arise with the use of these transformational imaging technologies. The Workshop convenes leading stakeholders from industry, academia, professional societies, government and patient advocacy to discuss progress and make recommendations about next steps.
Since 2004, the Quantitative Imaging Workshop focuses on the advancement of quantitative low-dose computerized tomography (LDCT) imaging biomarkers for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.
Beginning in 2013, each year at the Workshop the Prevent Cancer Foundation® presents the James L. Mulshine, M.D., National Leadership Award to an individual who has had a profound impact on reducing the toll these diseases take on the health of Americans and individuals around the world.
Past recipients of this award include:
2019 Meeting Report published in Translational Medicine Communications: Prevent Cancer Foundation quantitative CT imaging workshop XVI: lung cancer, COPD and cardiovascular disease – on the cusp of transformation, Arlington, VA
The Prevent Cancer Foundation® values its partnerships with its supporters and appreciates the impact we make together on increasing cancer screening and early detection. If your organization would like to support the Quantitative Imaging Workshop, or for more information on how you can become a corporate partner, please contact Becca Ginns at firstname.lastname@example.org.